Preventing repeat bleeding from stomach or upper gut ulcers
Treatments studied
Part of Digestive system clinical trials.
This trial studies medicines to help stop bleeding from coming back after you’ve had an “idiopathic” stomach/upper gut ulcer bleed. It may help by reducing ulcer re-bleeding risk in people who don’t have common causes like H. pylori or common ulcer-triggering drugs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’ve had a bleeding stomach or upper gut ulcer seen on endoscopy
- Your ulcer is “idiopathic,” meaning no clear cause like H. pylori or certain medicines/conditions in the prior weeks
- Your blood count (hemoglobin) is stable or back to your usual level since the last bleed
- Your age is 18 or older, and you can give consent (fingerprint is allowed if needed)
- You are not taking blood thinners or regular pain medicines like aspirin/NSAIDs or COX-2 inhibitors
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares an IV “acid-suppressing” medicine (PPI infusion) with acid pills (oral PPIs) after doctors treat a bleeding peptic ulcer endoscopically. It may help prevent re-bleeding by keeping stomach acid low while the ulcer heals.
This trial tests whether taking a high dose of omeprazole by mouth can help control bleeding from a peptic ulcer that looks high-risk on endoscopy. It may be aimed at lowering the chance of bleeding again after your procedure.
This trial tests a medication to help stop bleeding in the upper part of the stomach and esophagus. It may offer a new option for people with this urgent condition.
This trial tests whether a newer drug, tegoprazan, works as well as the standard drug lansoprazole for healing bleeding ulcers in the stomach or small intestine. You will get one of these drugs for 14 days and have a follow-up endoscopy to check healing.
This trial compares a potassium-competitive acid blocker to a proton pump inhibitor to help prevent stomach or intestinal bleeding in people at high risk who take blood-thinning medicines. It may help reduce dangerous GI bleeding while you stay on heart/stroke medicines.
This study tests a new medicine to help heal stomach ulcers. It may be an option if you have a stomach ulcer that is not too large and is at a certain stage of healing.
Hear when a new Active Peptic Ulcer Disease/GI Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.